COA/RT-2026-148Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Retatrutide 20 mg
RT-2026-148Lot RT20261029Analyzed November 20, 2026
Timeline
Ordered
November 16, 2026
Received
November 19, 2026
Analyzed
November 20, 2026
Sample
Name
Retatrutide 20 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder
Testing
Client
Umbrella Peptide Corp.
Test type
Content & purity
Method
HPLC-UV
Group test
Vials tested
1 vial, shared result
Contributors
5 people
Shared by
Matrix, Gloria Dominguez, Craig Jenkins, Peninsula LP, Ronnie Folomu
Content, how much is in it
19.27mg
Label claim: 20 mg
Purity, how clean it is
98.3%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.
Chromatogram
HPLC-UV
13.43 min, Retatrutide, 98.3%
Analyst Comments
White lyophilized powder, pink-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026
Verification Code
RT-M4VO-09EZ
Verify at purilab.org/verify/RT-M4VO-09EZ
Scan to Verify
RT-M4VO-09EZ
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1